(NASDAQ: BLFS) Biolife Solutions's forecast annual revenue growth rate of 19.45% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.76%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.56%.
Biolife Solutions's revenue in 2025 is $79,416,000.On average, 4 Wall Street analysts forecast BLFS's revenue for 2025 to be $4,652,766,675, with the lowest BLFS revenue forecast at $4,635,787,337, and the highest BLFS revenue forecast at $4,660,994,758.
In 2026, BLFS is forecast to generate $5,388,918,480 in revenue, with the lowest revenue forecast at $5,326,851,152 and the highest revenue forecast at $5,469,534,665.